histology, immunohistochemistry, western blot analyses and quantitative PCR. In vitro effects of GHRH were tested on human prostate epithelial (BPH-1) and stromal (WPMY-1) cell lines.
INTRODUCTION AND OBJECTIVES:
There is increasing evidence showing the positive correlation between prostatic inflammation and lower urinary tract symptoms (LUTS) in males with benign prostatic hyperplasia (BPH). Therefore, this study used a rat model of non-bacterial prostatic inflammation to investigate the changes in bladder activity and molecular characteristics of bladder afferent pathways and urothelium after prostatic inflammation.
METHODS: Male SD rats were used, and prostatic inflammation was induced by formalin (5%; 50 ml per lobe) injection into bilateral ventral lobes of the prostate. Bladder function was evaluated 1 and 4 weeks after formalin injection using awake cystometry. Also, after 10 days of prostatic inflammation, prostaglandin E2 (PGE2) concentrations in bladder tissues were measured by ELISA. In bladder mucosa, protein levels of TRPV1 and PGE2 receptors (EP1 to 4) as well as mRNA levels of ASICs (1-3), brain-derived neurotrophic factor (BDNF) and nerve growth factor (NGF) were evaluated by Western blot and RT-PCR, respectively. NGF immunoreactivity in bladder sections was also examined. In addition, mRNA levels of TRPV1 and TRPA1 receptors were measured in bladder afferent neurons labeled by Fast Blue (FB) injected into the bladder wall using laser-capture microdissection and RT-PCR methods.
RESULTS: Compared to vehicle-injected rats, formalin-treated rats exhibited a significant (p<0.05) decrease in intercontraction intervals in cystometry at 1 and 4 weeks after formalin injection. Tissue inflammation evident as inflammatory cell infiltration was found in the prostate, but not in the bladder from formalin-injected rats. In rats with prostatic inflammation (10 days), bladder PGE2 concentrations were significantly increased, and protein levels of TRPV1 and EP4 receptors as well as mRNA levels of all ASICs, BDNF and NGF were significantly elevated in bladder mucosa of formalin-injected rats. NGF immunoreactivity was also increased in bladder urothelium after prostatic inflammation. In FB-labeled bladder afferent neurons, mRNA levels of TRPV1 and TRPA1 were increased compared to non-labelled neurons in prostatic inflammation rats.
CONCLUSIONS: These results indicate that non-bacterial inflammation confined in the prostate induces bladder overactivity, enhanced PGE2 production in the bladder and upregulations of receptors and growth factors in bladder urothelium and/or afferent pathways, which could contribute to storage LUTS in BPH patients with prostatic inflammation. Recent studies in our laboratory demonstrated that prostate inflammation induced an increase in prostate collagen (fibrosis) and this finding suggested that inflammation-induced fibrosis in the human prostate contributes to development of bladder outlet obstruction (BOO). Using surgical specimens from a cohort of patients with BPH/LUTS, we performed quantitative analysis of inflammation and collagen content to test the hypothesis that histologic inflammation is positively correlated with prostate collagen content and to evaluate the role of fibrosis in BOO.
METHODS: We identified 44 men who underwent either TURP or open simple prostatectomy (OSP) for BPH/LUTS for whom preoperative urodynamic data were available. Prostate volume was calculated from CT or TRUS using the ellipsoid formula. Inflammation was quantitated using a consensus scoring system for prostate inflammation (Nickel, et al., 2001 ) and the total inflammation score represented the sum of stromal, epithelial and glandular inflammation. Collagen was quantitated using a previously validated quantitative method of picrosirius red staining for collagen and image J analysis (Wong et al., 2014) . Bladder outlet obstruction index (BOOI) was calculated from the formula BOOI ¼ PdetQmax -2Qmax.
RESULTS: The surgical cohort included 35 men (77%) who underwent TURP and 11 (23%) who underwent OSP. Median age was 63 ) and median prostate volume 48cc ). We observed a significant correlation between ) and linear regression analysis suggested the contribution of prostate enlargement to BOOI is greater for larger glands (>45g). We observed no significant correlation between inflammation and collagen content and no significant contribution of fibrosis to BOOI.
CONCLUSIONS: These data affirm a positive correlation of prostate volume with BOOI but do support the hypothesis that inflammation-induced fibrosis contributes to obstruction in most men. The suggestion that prostate volume makes a greater contribution to obstruction in larger glands suggests differing drivers of BOO in patients with smaller prostates. Vol. 199, No. 4S, Supplement, Saturday, May 19, 2018 THE JOURNAL OF UROLOGY â e599
